FREDRIC MINTZ: Open Payments
NPI 1194759530 · SYOSSET, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,133 in 50 payments from 15 companies in 2025. Trend: 2023 $948 · 2024 $1,213 · 2025 $1,133
Food & beverage: $1,133
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 15 | $386 |
| Novo Nordisk Inc | 10 | $195 |
| ABBVIE INC. | 4 | $90 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $75 |
| Braeburn Inc. | 3 | $73 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Eisai Inc. | 2 | $45 |
| Merck Sharp & Dohme LLC | 2 | $43 |
| Exact Sciences Corporation | 1 | $30 |
| PFIZER INC. | 1 | $29 |
Products named: FARXIGA, Wegovy, XIFAXAN, BRIXADI, AIRSUPRA, UBRELVY, Leqembi, GARDASIL 9.
Industry payments across NY — which companies pay providers there.
